Global Coronary Angioplasty Market - Strategic Insights and Forecasts (2026-2031)

The global coronary angioplasty market is expected to grow from USD 28.0 billion in 2026 to USD 37.3 billion by 2031, at a CAGR of 5.9%.

Major growth drivers include rising prevalence of coronary artery disease, increasing preference for minimally invasive procedures, expansion of drug-eluting stent adoption, and growing demand for complex lesion intervention technologies.

Lifestyle-related risk factors such as hypertension, diabetes, smoking, obesity, and sedentary behavior are increasing plaque buildup in arteries, leading to higher rates of ischemic heart disease and myocardial infarction.

Drug-eluting stents release medication that helps prevent restenosis, or re-narrowing of the artery, after implantation. They are increasingly preferred because they improve long-term vessel patency.

Stents, especially drug-eluting stents, remain the dominant product category due to their critical role in maintaining vessel scaffolding and reducing repeat interventions.